These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30838338)

  • 1. Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials.
    Kim DK; Lee JY; Jung JH; Hah YS; Cho KS
    Investig Clin Urol; 2019 Mar; 60(2):64-74. PubMed ID: 30838338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials.
    Leow JJ; Martin-Doyle W; Rajagopal PS; Patel CG; Anderson EM; Rothman AT; Cote RJ; Urun Y; Chang SL; Choueiri TK; Bellmunt J
    Eur Urol; 2014 Jul; 66(1):42-54. PubMed ID: 24018020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials.
    Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Oct; 8(46):81204-81214. PubMed ID: 29113380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients.
    Hamid ARAH; Ridwan FR; Parikesit D; Widia F; Mochtar CA; Umbas R
    BMC Urol; 2020 Oct; 20(1):158. PubMed ID: 33054762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we?
    Osanto S; Álvarez Gómez de Segura C
    Arch Esp Urol; 2020 Dec; 73(10):971-985. PubMed ID: 33269716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.
    Chen J; Zhang H; Sun G; Zhang X; Zhao J; Liu J; Shen P; Shi M; Zeng H
    Int J Surg; 2018 Apr; 52():214-220. PubMed ID: 29496649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis.
    Petrelli F; Coinu A; Cabiddu M; Ghilardi M; Vavassori I; Barni S
    Eur Urol; 2014 Feb; 65(2):350-7. PubMed ID: 23849998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis.
    Li G; Niu HM; Wu HT; Lei BY; Wang XH; Guo XB; Feng SL
    Clin Invest Med; 2017 Apr; 40(2):E81-E94. PubMed ID: 28447581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
    BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder.
    Dimopoulos MA; Moulopoulos LA
    J Clin Oncol; 1998 Apr; 16(4):1601-12. PubMed ID: 9552072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
    Meeks JJ; Bellmunt J; Bochner BH; Clarke NW; Daneshmand S; Galsky MD; Hahn NM; Lerner SP; Mason M; Powles T; Sternberg CN; Sonpavde G
    Eur Urol; 2012 Sep; 62(3):523-33. PubMed ID: 22677572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation.
    Kang DH; Cho KS; Moon YJ; Chung DY; Jung HD; Lee JY
    PLoS One; 2022; 17(4):e0267410. PubMed ID: 35446917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.
    Arcangeli G; Strigari L; Arcangeli S
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):387-96. PubMed ID: 25934521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Qu W; Zhao H; Yuan J
    BMC Cancer; 2019 Jul; 19(1):716. PubMed ID: 31324162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209.
    Kitamura H; Tsukamoto T; Shibata T; Masumori N; Fujimoto H; Hirao Y; Fujimoto K; Kitamura Y; Tomita Y; Tobisu K; Niwakawa M; Naito S; Eto M; Kakehi Y;
    Ann Oncol; 2014 Jun; 25(6):1192-8. PubMed ID: 24669010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant Chemotherapy for Different Stages of Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Liu S; Yao Y; Guan F; Sun L; Zhang G
    Dis Markers; 2022; 2022():8493519. PubMed ID: 35280442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
    Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why.
    Sylvester R; Sternberg C
    Ann Oncol; 2000 Jul; 11(7):851-6. PubMed ID: 10997813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.